Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q1 2023 · 10-Q
Revenue$19.67M$19.67M+22.0% vs Q1 2022 Net Income-$1.75M-$1.75MN/M vs Q1 2022 EPS Diluted-$0.10-$0.10N/M vs Q1 2022 Gross Profit$2,599,000N/M Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flow-$3,876,000N/M Margins · derivedGross margin13.2%+18.1 pt vs Q1 2022
Operating margin-7.3%+33.8 pt vs Q1 2022
Net margin-8.9%+35.5 pt vs Q1 2022
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end